Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 70010-185

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 70010-185). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Granules Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

150-mg-blister (150 mg Blister)

150-mg-blister (150 mg Blister)
FDA Label Image

150mg-carton-label (150 mg Carton Label)

150mg-carton-label (150 mg Carton Label)
The text provides information about a medication called Venlafaxine Hydrochloride Extended-Release Capsules. Each capsule contains 150 mg of venlafaxine hydrochloride. The usual dosage and storage instructions are not available. The medication is manufactured by Granules India Limited. The text also mentions the availability of a medication guide, which should be provided to each patient. Additional information such as lot number and expiration date is not readable.*
FDA Label Image

150-mg-container-label (150 mg Container Label 500)

150-mg-container-label (150 mg Container Label 500)
This text appears to be a description of a medication called Venlafaxine Hydrochloride Extended-Release Capsules. Each capsule contains 150 mg of venlafaxine. The usual dosage is not mentioned, and the description advises referring to the accompanying prescribing information. The text also includes instructions to keep the medication out of reach of children and provides a link to print medication guides. The manufacturer and distributor information is also included.*
FDA Label Image

37.5-mg-blister (37 5 mg Blister)

37.5-mg-blister (37 5 mg Blister)
Not available.*
FDA Label Image

37.5-mg-carton-label (37 5 mg Carton Label)

37.5-mg-carton-label (37 5 mg Carton Label)
This is a description of a medication called Venlafaxine Hydrochloride Extended-Release Capsules. Each capsule contains 37.5 mg of venlafaxine. The usual dosage information is provided in the accompanying prescribing information. The capsules should be stored at a temperature between 20° to 25°C (68° to 77°F). It is important to keep this medication out of the reach of children as the unit-dose package is not child-resistant. The medication guides can be printed from the website provided. The capsules are manufactured by Granules India Limited in Hyderabad, India. The manufactured units are for Granules Pharmaceuticals Inc. in Chantilly, VA. The package contains 80 unit-dose capsules. The National Drug Code (NDC) for this medication is 70010-184-63. The lot and expiration date information is not available from the given text.*
FDA Label Image

37.5-mg-container-label (37 5 mg Container Label)

37.5-mg-container-label (37 5 mg Container Label)
This is a description of a medication called Venlafaxine Hydrochloride Extended-Release Capsules. Each capsule contains 37.5 mg of Venlafaxine. The usual dosage can be found in the prescribing information. The medication is dispensed in a tight container and should be kept out of reach of children. The medication guide can be obtained from the given website. It is manufactured by Granules Pharmaceuticals Inc.*
FDA Label Image

37.5-mg-blister (75 mg Blister)

37.5-mg-blister (75 mg Blister)
Not available.*
FDA Label Image

75mg-carton-label (75 mg Carton Label)

75mg-carton-label (75 mg Carton Label)
Each extended-release capsule contains 75 mg of venlafaxine hydrochloride. The usual dosage is to be determined based on the accompanying prescribing information. The medication should be stored at a temperature of 20°C to 25°C. The package is not child-resistant, so it should be kept out of reach of children. The medication guide can be printed from the website of Granules Pharmaceuticals Inc. The capsules are manufactured by Granules India Limited. The product is intended for distribution by Granules Pharmaceuticals Inc. The NDC number for the product is 70010-185-63.*
FDA Label Image

75mg-container-label (75 mg Container Label)

75mg-container-label (75 mg Container Label)
This text appears to be a description of a medication called Venlafaxine Hydrochloride. Each extended-release capsule contains 75 mg of venlafaxine. The usual dosage instructions are not provided in this text, so additional information would need to be consulted. The text also includes information about keeping the medication out of reach of children and provides a link for printing medication guides. It mentions that the medication guide should be dispensed separately to each patient. The manufacturer is Granules Pharmaceuticals Inc. with an address in Chantilly, VA. The expiration date is not provided.*
FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
FDA Label Image

Structure (Structure)

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.